These data will be used to further understand the biomarker of grey matter density (GMD) in relation to schizophrenia, schizoaffective disorder, and bipolar disorder with psychosis and their heredity. This research will enhance the conceptual understanding of the biotypes of these disorders introduced through the results of the Bipolar and Schizophrenia Network for Intermediate Phenotypes (BSNIP) project by conducting analyses of the effects of alcohol misuse.
These data will be used to further understand the biomarker of grey matter density (GMD) in relation to schizophrenia, schizoaffective disorder, and bipolar disorder with psychosis and their heredity. This research will enhance the conceptual understanding of the biotypes of these disorders introduced through the results of the Bipolar and Schizophrenia Network for Intermediate Phenotypes (BSNIP) project by conducting analyses of the effects of alcohol misuse.